Effect of Etiology and Timing of Respiratory Tract Infections on Development of Bronchiolitis Obliterans Syndrome

Journal of Heart and Lung Transplantation

Volumn 28, Issue 2, 2009, Pages 163-169

  Valentine, Vincent G ^a   Gupta, Meera R ^a   Walker Jr , James E ^b   Seoane, Leonardo ^b   Bonvillain, Ryan W ^c   Lombard, Gisele A ^a   Weill, David ^d   Dhillon, Gundeep S ^d  

^a University of Texas Medical Branch School of Medicine   (United States)

^b OCHSNER MEDICAL CENTER   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; BRONCHIOLITIS OBLITERANS; CHILD; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; FEMALE; GRAFT RECIPIENT; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HUMAN; LUNG GRAFT REJECTION; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCHOOL CHILD; SURVIVAL TIME; VIRUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; BRONCHIOLITIS OBLITERANS; CHILD; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; GRAM-NEGATIVE BACTERIAL INFECTIONS; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INCIDENCE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; MYCOSES; PNEUMONIA; POSTOPERATIVE COMPLICATIONS; RESPIRATORY TRACT INFECTIONS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; YOUNG ADULT;

EID: 59349108263     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2008.11.907     Document Type: Article

References (44)

1. 1 and the development of bronchiolitis obliterans syndrome: an important confounder?. J Heart Lung Transplant 26 (2007) 1127-1134
2. Heng D., Sharples L.D., McNeil K., et al. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant 17 (1998) 1255-1263
3. Meyers B.F., Lynch J., Trulock E.P., et al. Lung transplantation: a decade of experience. Ann Surg 230 (1999) 362-370
4. Valentine V.G., Robbins R.C., Berry G.J., et al. Actuarial survival of heart-lung and bilateral sequential lung transplant recipients with obliterative bronchiolitis. J Heart Lung Transplant 15 (1996) 371-383
5. Nicod L.P. Mechanisms of airway obliteration after lung transplantation. Proc Am Thorac Soc 3 (2006) 444-449
6. Yousem S.A., Berry G.J., Cagle P.T., et al. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection. J Heart Lung Transplant 15 (1996) 1-15
7. Boehler A., and Estenne M. Obliterative bronchiolitis after lung transplantation. Curr Opin Pulmon Med 6 (2000) 133-139
8. Halloran P.F., Homik J., Goes N., et al. The "injury response": a concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 29 (1997) 79-81
9. Bando K., Paradis I.L., Similo S., et al. Obliterative bronchiolitis after lung and heart-lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg 110 (1995) 4-13
10. Boehler A., and Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J 22 (2003) 1007-1018
11. Girgis R.E., Tu I., Berry G.J., et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant 15 (1996) 1200-1208
12. Husain A.N., Siddiqui M.T., Holmes E.W., et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med 159 (1999) 829-833
13. Keller C.A., Cagle P.T., Brown R.W., Noon G., and Frost A.E. Bronchiolitis obliterans in recipients of single, double, and heart-lung transplantation. Chest 107 (1995) 973-980
14. Kesten S., Maidenberg A., Winton T., and Maurer J. Treatment of presumed and proven acute rejection following six months of lung transplant survival. Am J Respir Crit Care Med 152 (1995) 1321-1324
15. Kroshus T.J., Kshettry V.R., Savik K., et al. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg 114 (1997) 195-202
16. Glanville A.R., Aboyoun C.L., Havryk A., et al. Severity of lymphocytic bronchiolitis predicts long term outcome after lung transplantation. Am J Respir Crit Care Med 177 (2008) 1033-1040
17. Girnita A.L., Duquesnoy R., Yousem S.A., et al. HLA-specific antibodies are risk factors for lymphocytic bronchiolitis and chronic lung allograft dysfunction. Am J Transplant 5 (2005) 131-138
18. Sundaresan S., Mohanakumar T., Smith M.A., et al. HLA-A locus mismatches and development of antibodies to HLA after lung transplantation correlate with the development of bronchiolitis obliterans syndrome. Transplantation 65 (1998) 648-653
19. Langenbach S.Y., Zheng L., McWilliams T., et al. Airway vascular changes after lung transplant: potential contribution to the pathophysiology of bronchiolitis obliterans syndrome. J Heart Lung Transplant 24 (2005) 1550-1556
20. Duncan S.R., Paradis I.L., Yousem S.A., et al. Sequelae of cytomegalovirus pulmonary infections in lung allograft recipients. Am Rev Respir Dis 146 (1992) 1419-1425
21. Fishman J.A., and Rubin R.H. Infection in organ-transplant recipients. N Engl J Med 338 (1998) 1741-1751
22. Bonvillain R.W., Valentine V.G., Lombard G., et al. Post-operative infections in cystic fibrosis and non-cystic fibrosis patients after lung transplantation. J Heart Lung Transplant 26 (2007) 890-897
23. Gunderson C.C., Gupta M.R., Lopez F., et al. Clostridium difficile colitis in lung transplantation. Transplant Infect Dis 10 (2008) 245-251
24. Valentine V.G., Taylor D.E., Dhillon G.S., et al. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant 21 (2002) 319-326
25. Cooper J.D., Billingham M., Egan T., et al. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts. J Heart Lung Transplant 12 (1993) 713-716
26. Valentine V.G., Bonvillain R.W., Gupta M.R., et al. Infections in lung allograft recipients: ganciclovir era. J Heart Lung Transplant 27 (2008) 528-535
27. Moffatt S.D., Demers P., Robbins R.C., et al. Lung transplantation: a decade of experience. J Heart Lung Transplant 24 (2005) 145-151
28. Sharples L.D., Tamm M., McNeil K., et al. Development of bronchiolitis obliterans syndrome in recipients of heart-lung transplantation-early risk factors. Transplantation 61 (1996) 560-566
29. Burton C.M., Carlsen J., Mortensen J., et al. Long-term survival after lung transplantation depends on development and severity of bronchiolitis obliterans syndrome. J Heart Lung Transplant 26 (2007) 681-686
30. Khalifah A.P., Hachem R.R., Chakinala M.M., et al. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant 5 (2005) 2022-2030
31. Hopkins P.M., Aboyoun C.L., Chhajed P.N., et al. Association of minimal rejection in lung transplant recipients with obliterative bronchiolitis. Am J Respir Critical Care Med 170 (2004) 1022-1026
32. Khalifah A.P., Hachem R.R., Chakinala M.M., et al. Respiratory viral infections are a distinct risk for bronchiolitis obliterans syndrome and death. Am J Respir Crit Care Med 170 (2004) 181-187
33. Kumar D., Erdman D., Keshavjee S., et al. Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant. Am J Transplant 5 (2005) 2031-2036
34. Heeger P.S., Greenspan N.S., Kuhlenschmidt S., et al. Pretransplant frequency of donor-specific, IFN-gamma-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 163 (1999) 2267-2275
35. Ashwell J.D., Chen C., and Schwartz R.H. High frequency and nonrandom distribution of alloreactivity in T cell clones selected for recognition of foreign antigen in association with self class II molecules. J Immunol 136 (1986) 389-395
36. Lechler R.I., Heaton T., Barber L., et al. Molecular mimicry by major histocompatibility complex molecules and peptides accounts for some alloresponses. Immunol Lett 34 (1992) 63-69
37. Valujskikh A. Memory T cells in allograft rejection. Adv Exper Med Biol 601 (2007) 247-256
38. Ahmed R., and Gray D. Immunological memory and protective immunity: understanding their relation. Science (NY) 272 (1996) 54-60
39. Cakala M., and Olszewski W.L. Memory response in allografting and bacterial infections in lymphoid and non-lymphoid tissues. Ann Transplant 11 (2006) 38-44
40. Adams A.B., Williams M.A., Jones T.R., et al. Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 111 (2003) 1887-1895
41. Brook M.O., Wood K.J., and Jones N.D. The impact of memory T cells on rejection and the induction of tolerance. Transplantation 82 (2006) 1-9
42. Lanzavecchia A., and Sallusto F. Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells. Science (NY) 290 (2000) 92-97
43. + regulatory T cells are spared from deletion by antilymphocyte serum, a polyclonal anti-T cell antibody. J Immunol 176 (2006) 4125-4132
44. + effector and memory T cell generation. Nat Immunol 4 (2003) 835-842